Brief mindfulness meditation based on Buddhist Anapanasati regulates stress response in young Chinese males.

Anxiety Stress CopingApr 7, 2026 (epub)
Clinical ResearchPsychiatry

Xiao-Na Zhou, Jun-Lan Liu, Jia-Hui Guo et al.

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial evaluated a two-week, 15-minute-daily Brief Mindfulness Meditation intervention based on Buddhist Anapanasati in 85 Chinese men aged 20–30, compared with neutral audio. Assessments covered perceived stress, affect, mindfulness, heart-rate variability and cortisol. Relative to control, meditation reduced perceived stress (-5.00, 95% CI [-9.50, -0.52]) and the LF/HF ratio (-0.65, 95% CI [-1.16, -0.13]), and increased positive affect (7.39, 95% CI [3.81, 10.97]) and Acting with Awareness. Mediation analyses linked improved positive affect to reduced perceived stress and changes in negative affect partly to greater Acting with Awareness.

Key findings

  • Compared with control, perceived stress decreased by -5.00 (95% CI [-9.50, -0.52]) in the meditation group.
  • The LF/HF ratio decreased by -0.65 (95% CI [-1.16, -0.13]) relative to control.
  • Positive affect increased by 7.39 (95% CI [3.81, 10.97]) compared with control.
  • Mediation analyses indicated that reduced perceived stress fully mediated the positive-affect effect; increased Acting with Awareness partly mediated the negative-affect effect.

Why it matters

The findings suggest that a brief, structured mindfulness intervention may influence both perceived stress and selected emotional and physiological measures in young men. The mediation results offer possible explanations for how emotional outcomes may relate to stress reduction and mindful awareness, although they do not establish these pathways as causal mechanisms beyond the study’s analyses.

What to keep in mind

The study involved young Chinese men, so the findings may not generalize to other populations. Outcomes were assessed before and after a two-week intervention; longer-term effects are not reported.

Source

Published in Anxiety Stress Coping. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.